Page last updated: 2024-08-21

cyclopentane and Graft-Versus-Host Disease

cyclopentane has been researched along with Graft-Versus-Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, H; Mathewson, ND; Oravecz-Wilson, K; Reddy, P; Rossi, C; Sun, Y; Toubai, T; Wu, SR; Zajac, C1
Abedi, M; Chen, M; Khuat, LT; Murphy, WJ; Pai, CS1

Other Studies

2 other study(ies) available for cyclopentane and Graft-Versus-Host Disease

ArticleYear
SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.
    The American journal of pathology, 2016, Volume: 186, Issue:10

    Topics: Animals; Carrier Proteins; Cyclopentanes; Female; Gene Expression Profiling; Graft vs Host Disease; Humans; Immunity, Cellular; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; T-Lymphocytes; Ubiquitin-Protein Ligases; Ubiquitination

2016
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:1

    Topics: Animals; Antigen-Presenting Cells; Cyclopentanes; Enzyme Inhibitors; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell; Mice; Pyrimidines; Scleroderma, Systemic; T-Lymphocytes; Time Factors; Transplantation, Homologous; Ubiquitin-Activating Enzymes

2017